Furthermore, these analyses demonstrated higher ApoE levels in the context of MetS, higher non-HDL cholesterol, HDL cholesterol, ApoB and ApoA-1 as well as higher ApoE levels in ε2 carriers and lower ApoE levels in ε4 carriers (Table 2, Models 2–5). This evidence concerns the gene APOA1 and metabolic syndrome.